PEOPLE ON THE MOVE
Mark Weinberg made CMO of Avillion
Avillion LLP has appointed Mark Weinberg as its Chief medical officer (CMO), to be based in Chicago, US.
Avillion is a London drug development company which focuses on clinical co-development and regulatory approval of late stage pharmaceutical products.
Weinberg was previously CMO and Managing Director of Halloran Consulting Group, and prior to this Senior Vice President of Clinical Development at US biotech company RestorGenex Pharmaceuticals.
Other appointments have included roles at Astellas Pharma Global Development, Lundbeck Inc. (formerly Ovation Pharmaceuticals), Takeda Global Research and Development and Abbott Laboratories.
